Certolizumab pegol as treatment for Crohn's disease in a community IBD practice

被引：0
|
作者：
Shafran, Ira [1 ]
Burgunder, Patricia [1 ]
Fakih, Faisal [1 ]
机构：
[1] Shafran Gastroenterol Ctr, Winter Pk, FL USA
来源：
INFLAMMATORY BOWEL DISEASES | 2011年 / 17卷
关键词：
D O I：
10.1097/00054725-201112002-00088
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [21] Severe Crohn's disease symptoms are relieved by certolizumab pegol
    Feagan, Brian G.
    Coteur, Geoffroy
    Keininger, Doroth L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S471 - S471
  • [22] Certolizumab pegol: A guide to its use in Crohn's disease
    不详
    Drugs & Therapy Perspectives, 2007, 23 (11) : 5 - 8
  • [23] Efficacy of Certolizumab Pegol Therapy in Patients With Crohn's Disease
    Shafran, Ira
    Al-Maani, Sayel
    Burgunder, Patricia
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S451 - S451
  • [24] CERTOLIZUMAB PEGOL IN CROHN'S DISEASE REFRACTORY TO INFLIXIMAB AND ADALIMUMAB
    Jose, Morales Lara Ma
    Penella Monica, Martinez
    Guzman Diana, Lacruz
    Vidal Vanessa, Jorge
    Maneiro Vicente, Santaclara
    Sanchez Senador, Moran
    del Carmen, Mira Sirvent Ma
    ATENCION FARMACEUTICA, 2009, 11 (03): : 178 - 180
  • [25] Oral lichen planus after certolizumab pegol treatment in a patient with Crohn's disease
    Mocciaro, Filippo
    Orlando, Ambrogio
    Renna, Sara
    Rizzuto, Maria Rosa
    Cottone, Mario
    JOURNAL OF CROHNS & COLITIS, 2011, 5 (02): : 173 - 174
  • [26] Safety Profile of Extraintestinal Manifestations of Crohn's Disease During Treatment With Certolizumab Pegol
    Randall, Charles W.
    Wolf, Douglas C.
    Spearman, Marshall
    Kosutic, Gordana
    Coarse, Jason
    Loftus, Edward V., Jr.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S780 - S781
  • [27] Health outcomes and cost-effectiveness of certolizumab pegol in the treatment of Crohn's disease
    Augustine, Jill M.
    Lee, Jeannie K.
    Armstrong, Edward P.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2014, 14 (05) : 599 - 609
  • [28] Does Obesity Impact Treatment Efficacy of Adalimumab and Certolizumab Pegol in Crohn's Disease?
    Click, Benjamin
    Tuskey, Anne G.
    Behm, Brian W.
    GASTROENTEROLOGY, 2012, 142 (05) : S361 - S361
  • [29] CIMZIA (Certolizumab Pegol) is effective in the treatment of Crohn's Disease patients with open fistulas
    Schreiber, S.
    Lawranc, I
    Thomsen, O.
    Hanauer, S.
    Bloomfield, R.
    Sandborn, W.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : S1 - S1
  • [30] Adalimumab and Certolizumab Pegol for the Treatment of Crohn's Disease: Does BMI Make a Difference?
    Moore, John M.
    Beaulieu, Dawn B.
    Horst, Sara N.
    Armstrong, Sharelle
    Duncan, Pamela A.
    Wagnon, Julianne H.
    Duley, Caroline
    Ward, Jodie
    Rosenbury, Audra
    Schwartz, David A.
    GASTROENTEROLOGY, 2011, 140 (05) : S588 - S588
12345